Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregg M Lanier

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Journal of the American College of Cardiology|August 22, 2015
New Insights and Clarity for Peripartum Heart Failure and Recovery in the Modern EraGregg M Lanier
Cardiology in Review|August 12, 2014
Peripartum cardiomyopathy: definition, incidence, etiopathogenesis, diagnosis, and managementJalaj Garg, Chandrasekar Palaniswamy, Gregg M Lanier
Cardiology in Review|April 14, 2020
Nonpharmacologic Treatment for Heart Failure: A Review of Implantable Carotid Baroreceptor Stimulators As a Therapeutic OptionBoniface Malangu, Gregg M Lanier, William H Frishman
Journal of Cardiac Surgery|November 1, 2022
Heart transplantation using manubrium-sparing sternotomy for sternal re-entrySuguru Ohira, David Spielvogel, Gregg M Lanier, et al.
Cardiology Clinics|November 19, 2018
Role of Advanced Testing: Invasive Hemodynamics, Endomyocardial Biopsy, and Cardiopulmonary Exercise TestingGregg M Lanier, John T Fallon, Srihari S Naidu
Respiratory Medicine Case Reports|November 8, 2021
Acute amiodarone pulmonary toxicity in the form of organizing pneumonia triggered by orthotopic heart transplantationNatalya Kozlova, Gregg M Lanier, George Kleinman, et al.
Expert Opinion on Investigational Drugs|May 4, 2024
The role of phosphodiesterase 9A inhibitors in heart failureSaam Foroshani, Avrohom Karp, Wilbert S Aronow, et al.
European Heart Journal. Case Reports|September 24, 2021
A haemodynamic conundrum: a case report of a patient with concurrent pulmonary arterial hypertension and hypertrophic obstructive cardiomyopathyAhmed Hassanin, Wojciech Rzechorzek, Srihari S Naidu, et al.
Therapeutics and Clinical Risk Management|January 16, 2025
The Role of Intravenous Selexipag in Managing PAH and Bridging Gaps in Oral Treatment: A Narrative ReviewSienna Goren, Nermeen Kidwai, Wilbert S Aronow, et al.
Expert Opinion on Investigational Drugs|May 16, 2019
Novel drug therapies for cardiac amyloidosisPrakash Harikrishnan, Srikanth Yandrapalli, Wilbert S Aronow, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Journal of the American College of Cardiology|August 22, 2015
New Insights and Clarity for Peripartum Heart Failure and Recovery in the Modern EraGregg M Lanier
Cardiology in Review|August 12, 2014
Peripartum cardiomyopathy: definition, incidence, etiopathogenesis, diagnosis, and managementJalaj Garg, Chandrasekar Palaniswamy, Gregg M Lanier
Cardiology in Review|April 14, 2020
Nonpharmacologic Treatment for Heart Failure: A Review of Implantable Carotid Baroreceptor Stimulators As a Therapeutic OptionBoniface Malangu, Gregg M Lanier, William H Frishman
Journal of Cardiac Surgery|November 1, 2022
Heart transplantation using manubrium-sparing sternotomy for sternal re-entrySuguru Ohira, David Spielvogel, Gregg M Lanier, et al.
Cardiology Clinics|November 19, 2018
Role of Advanced Testing: Invasive Hemodynamics, Endomyocardial Biopsy, and Cardiopulmonary Exercise TestingGregg M Lanier, John T Fallon, Srihari S Naidu
Respiratory Medicine Case Reports|November 8, 2021
Acute amiodarone pulmonary toxicity in the form of organizing pneumonia triggered by orthotopic heart transplantationNatalya Kozlova, Gregg M Lanier, George Kleinman, et al.
Expert Opinion on Investigational Drugs|May 4, 2024
The role of phosphodiesterase 9A inhibitors in heart failureSaam Foroshani, Avrohom Karp, Wilbert S Aronow, et al.
European Heart Journal. Case Reports|September 24, 2021
A haemodynamic conundrum: a case report of a patient with concurrent pulmonary arterial hypertension and hypertrophic obstructive cardiomyopathyAhmed Hassanin, Wojciech Rzechorzek, Srihari S Naidu, et al.
Therapeutics and Clinical Risk Management|January 16, 2025
The Role of Intravenous Selexipag in Managing PAH and Bridging Gaps in Oral Treatment: A Narrative ReviewSienna Goren, Nermeen Kidwai, Wilbert S Aronow, et al.
Expert Opinion on Investigational Drugs|May 16, 2019
Novel drug therapies for cardiac amyloidosisPrakash Harikrishnan, Srikanth Yandrapalli, Wilbert S Aronow, et al.
Pageof 8